Schistosomiasis: The Need for a Tailored-Made Treatment for Preschoolers  - Takeaways - MDSpire

Schistosomiasis: The Need for a Tailored-Made Treatment for Preschoolers 

About the Pediatric Praziquantel Consortium, and why a child-friendly treatment for preschool-aged children with schistosomiasis was needed

  • January 15, 2026

  • 13 min

Share

  • 1

    Schistosomiasis causes chronic inflammation and can impair growth and cognitive development in preschoolers.

  • 2

    Praziquantel is effective for older children and adults, but a child-friendly formulation was needed for preschoolers.

  • 3

    The Pediatric Praziquantel Consortium was launched in 2012 to develop a suitable treatment for children aged three months to six years.

  • 4

    A new formulation received positive scientific opinion from the EMA in December 2023 and WHO prequalification in May 2024.

  • 5

    The project faced challenges in taste and formulation, requiring innovative approaches to ensure acceptability for young children.

Original Source(s)

Schistosomiasis: The Need for a Tailored-Made Treatment for Preschoolers 

  • January 15, 2026

Related Content

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

Long-term epidemiological patterns of pediatric infectious diseases in an urban district of Shanghai, 2015–2023

FDA OKs Linaclotide in Young Children

Phase 3 data expanded use of linaclotide 72 mcg in pediatric functional constipation.